{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:49:41Z","timestamp":1794642581712,"version":"4.9.1"},"reference-count":461,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1079187"],"award-info":[{"award-number":["1079187"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1175134"],"award-info":[{"award-number":["1175134"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.pharmthera.2021.107839","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T11:17:41Z","timestamp":1616671061000},"page":"107839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":235,"special_numbering":"C","title":["Therapeutic targets in lung tissue remodelling and fibrosis"],"prefix":"10.1016","volume":"225","author":[{"given":"Gang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh M.","family":"Philp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamera","family":"Corte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Schilter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole G.","family":"Hansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew S.","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhwinder S.","family":"Sohal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette K.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Hansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2021.107839_bb0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1097-4652(199802)174:2<186::AID-JCP6>3.0.CO;2-K","article-title":"Cell-associated activation of latent transforming growth factor-beta by calpain","volume":"174","author":"Abe","year":"1998","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0010","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1983","article-title":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis","volume":"6","author":"Adams","year":"2020","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1983","article-title":"Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis","volume":"6","author":"Adams","year":"2020","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1165\/rcmb.2017-0200TR","article-title":"Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease: Role of cigarette smoke exposure","volume":"58","author":"Aghapour","year":"2018","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0025","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1900475","article-title":"Update on the pathogenesis of chronic obstructive pulmonary disease","volume":"381","author":"Agusti","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0030","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S2213-2600(17)30387-9","article-title":"Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study","volume":"5","author":"Allen","year":"2017","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0035","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaci.2011.04.047","article-title":"Remodeling in asthma","volume":"128","author":"Al-Muhsen","year":"2011","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1357-2725(02)00259-5","article-title":"Airway smooth muscle: contraction and beyond","volume":"35","author":"Amrani","year":"2003","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0045","doi-asserted-by":"crossref","first-page":"H700","DOI":"10.1152\/ajpheart.00326.2005","article-title":"Endothelin-1 expression in vascular adventitial fibroblasts","volume":"290","author":"An","year":"2006","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/glycob\/cwu120","article-title":"Versican in inflammation and tissue remodeling: The impact on lung disorders","volume":"25","author":"Andersson-Sjoland","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0055","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1183\/09031936.00192611","article-title":"Extracellular matrix composition in COPD","volume":"40","author":"Annoni","year":"2012","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1183\/09031936.00147807","article-title":"Extracellular matrix components and regulators in the airway smooth muscle in asthma","volume":"32","author":"Araujo","year":"2008","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0065","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1172\/JCI32526","article-title":"Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients","volume":"117","author":"Araya","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0092-8674(89)90097-4","article-title":"Fibulin, a novel protein that interacts with the fibronectin receptor beta subunit cytoplasmic domain","volume":"58","author":"Argraves","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0075","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.embor.7400033","article-title":"Fibulins: physiological and disease perspectives","volume":"4","author":"Argraves","year":"2003","journal-title":"EMBO Reports"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0080","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41598-017-01476-y","article-title":"In vitro fibrillogenesis of tropocollagen type III in collagen type I affects its relative fibrillar topology and mechanics","volume":"7","author":"Asgari","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0085","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1164\/rccm.201703-0605ED","article-title":"Vascular endothelial growth factor in idiopathic pulmonary fibrosis. An imbalancing act","volume":"196","author":"Atamas","year":"2017","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0090","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.6061\/clinics\/2012(11)19","article-title":"Airway disease: Similarities and differences between asthma, COPD and bronchiectasis","volume":"67","author":"Athanazio","year":"2012","journal-title":"Clinics (S\u00e3o Paulo, Brazil)"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0095","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.matbio.2005.05.006","article-title":"A simplified laminin nomenclature","volume":"24","author":"Aumailley","year":"2005","journal-title":"Matrix Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0100","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1164\/ajrccm.162.2.9907151","article-title":"The effect of age and duration of disease on airway structure in fatal asthma","volume":"162","author":"Bai","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/CS20040342","article-title":"Structural changes in the airways in asthma: Observations and consequences","volume":"108","author":"Bai","year":"2005","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0110","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1183\/09031936.00165106","article-title":"Severe exacerbations predict excess lung function decline in asthma","volume":"30","author":"Bai","year":"2007","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0115","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1183\/09031936.00019810","article-title":"Pathophysiology of bronchial smooth muscle remodelling in asthma","volume":"36","author":"Bara","year":"2010","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/thx.2003.012146","article-title":"Neutrophilic infiltration within the airway smooth muscle in patients with COPD","volume":"59","author":"Baraldo","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0125","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.200602-189OC","article-title":"Epithelial damage and angiogenesis in the airways of children with asthma","volume":"174","author":"Barbato","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0130","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaci.2012.11.053","article-title":"A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis","volume":"131","author":"Beckett","year":"2013","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66630-5","article-title":"Single-cell RNA sequencing reveals that lung mesenchymal progenitor cells in IPF exhibit pathological features early in their differentiation trajectory","volume":"10","author":"Beisang","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0140","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01857-2017","article-title":"Macitentan reduces progression of TGF-beta1-induced pulmonary fibrosis and pulmonary hypertension","volume":"52","author":"Bellaye","year":"2018","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0145","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1165\/rcmb.2002-0009OC","article-title":"Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis","volume":"27","author":"Belperio","year":"2002","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0150","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1164\/rccm.200209-1030OC","article-title":"Airway structural alterations selectively associated with severe asthma","volume":"167","author":"Benayoun","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11703","article-title":"Tenascin-C drives persistence of organ fibrosis","volume":"7","author":"Bhattacharyya","year":"2016","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fphys.2015.00346","article-title":"Airway and extracellular matrix mechanics in COPD","volume":"6","author":"Bidan","year":"2015","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0165","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/j.1582-4934.2008.00490.x","article-title":"ADAM15 modulates outside-in signalling in chondrocyte-matrix interactions","volume":"13","author":"Bohm","year":"2009","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0170","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0175","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jaci.2007.01.055","article-title":"Specificity of basement membrane thickening in severe asthma","volume":"119","author":"Bourdin","year":"2007","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0180","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01346-2019","article-title":"TRIM33 prevents pulmonary fibrosis by impairing TGF-beta1 signalling","volume":"55","author":"Boutanquoi","year":"2020","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0185","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1365-2222.2007.02808.x","article-title":"Cigarette smoke-induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5-deficient mice","volume":"37","author":"Bracke","year":"2007","journal-title":"Clinical and Experimental Allergy"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/thoraxjnl-2014-205091","article-title":"A large lung gene expression study identifying fibulin-5 as a novel player in tissue repair in COPD","volume":"70","author":"Brandsma","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","article-title":"The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity","volume":"1803","author":"Brew","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0200","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000485933","article-title":"Real-world experience with nintedanib in patients with idiopathic pulmonary fibrosis","volume":"95","author":"Brunnemer","year":"2018","journal-title":"Respiration"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0205","article-title":"Single-cell RNA-sequencing reveals dysregulation of molecular programs associated with SARS-CoV-2 severity and outcomes in patients with chronic lung disease","author":"Bui","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0210","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1164\/rccm.200904-0631OC","article-title":"Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness","volume":"181","author":"Burgess","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0215","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcp.21450","article-title":"Dual ERK and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: differences in asthma","volume":"216","author":"Burgess","year":"2008","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/path.4808","article-title":"The extracellular matrix - the under-recognized element in lung disease?","volume":"240","author":"Burgess","year":"2016","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0225","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jaci.2006.05.019","article-title":"A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro","volume":"118","author":"Burgess","year":"2006","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0230","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01805-2016","article-title":"The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease","volume":"50","author":"Burgstaller","year":"2017","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0235","first-page":"121","article-title":"Arteriogenesis versus angiogenesis: Two mechanisms of vessel growth","volume":"14","author":"Buschmann","year":"1999","journal-title":"News in Physiological Sciences"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0240","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0245","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1172\/JCI65570","article-title":"Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease","volume":"123","author":"Byers","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0250","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.rmed.2005.11.009","article-title":"Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction","volume":"100","author":"Calabrese","year":"2006","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0255","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2559.2004.01952.x","article-title":"Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease","volume":"45","author":"Caramori","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0260","doi-asserted-by":"crossref","first-page":"L785","DOI":"10.1152\/ajplung.00385.2009","article-title":"Tenascin-C deficiency attenuates TGF-ss-mediated fibrosis following murine lung injury","volume":"299","author":"Carey","year":"2010","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"11","key":"10.1016\/j.pharmthera.2021.107839_bb0265","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1164\/rccm.201904-0792OC","article-title":"Single cell reconstruction of human basal cell diversity in normal and IPF lung","volume":"202","author":"Carraro","year":"2020","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0270","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/ajrccm\/147.2.405","article-title":"The structure of large and small airways in nonfatal and fatal asthma","volume":"147","author":"Carroll","year":"1993","journal-title":"The American Review of Respiratory Disease"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0275","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1164\/ajrccm.155.2.9032214","article-title":"Bronchial blood vessel dimensions in asthma","volume":"155","author":"Carroll","year":"1997","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0280","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1165\/rcmb.2005-0386OC","article-title":"Epidermal growth factor receptor activation by epidermal growth factor mediates oxidant-induced goblet cell metaplasia in human airway epithelium","volume":"34","author":"Casalino-Matsuda","year":"2006","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0285","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000024452","article-title":"MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease","volume":"123","author":"Cataldo","year":"2000","journal-title":"International Archives of Allergy and Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0290","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1067\/mai.2003.1557","article-title":"Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression","volume":"111","author":"Chakir","year":"2003","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0295","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1164\/ajrccm.159.2.9801022","article-title":"Comparison between nasal and bronchial inflammation in asthmatic and control subjects","volume":"159","author":"Chanez","year":"1999","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0300","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/cea.12506","article-title":"Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come","volume":"45","author":"Chapman","year":"2015","journal-title":"Clinical and Experimental Allergy"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0305","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00439-008-0571-z","article-title":"MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis","volume":"124","author":"Checa","year":"2008","journal-title":"Human Genetics"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0310","article-title":"Differential regulation of extracellular matrix and soluble fibulin-1 levels by TGF-beta(1) in airway smooth muscle cells","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0315","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.200207-710OC","article-title":"Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone","volume":"167","author":"Chetta","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0320","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1465-9921-13-3","article-title":"The pathogenesis of COPD and IPF: distinct horns of the same devil?","volume":"13","author":"Chilosi","year":"2012","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0325","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.matbio.2014.01.007","article-title":"Tenascins in stem cell niches","volume":"37","author":"Chiquet-Ehrismann","year":"2014","journal-title":"Matrix Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0330","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0002-9440(10)63371-8","article-title":"Transforming growth factor-beta2 induces bronchial epithelial mucin expression in asthma","volume":"165","author":"Chu","year":"2004","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0335","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1172\/JCI114045","article-title":"Effects of interferon-gamma on expression of cell surface receptors for collagen and deposition of newly synthesized collagen by cultured human lung fibroblasts","volume":"83","author":"Clark","year":"1989","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0340","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/thorax.56.1.25","article-title":"Ultrastructural examination of bronchial biopsy specimens from children with moderate asthma","volume":"56","author":"Cokugras","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0345","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejps.2014.02.014","article-title":"Effect of pirfenidone on proliferation, TGF-beta-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts","volume":"58","author":"Conte","year":"2014","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0350","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s00018-013-1494-y","article-title":"The role of periostin in tissue remodeling across health and disease","volume":"71","author":"Conway","year":"2014","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0355","series-title":"The extracellular matrix: An overview","first-page":"337","article-title":"The fibulins","author":"Cooley","year":"2011"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0360","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ydbio.2008.04.029","article-title":"Fibulin-1 is required for morphogenesis of neural crest-derived structures","volume":"319","author":"Cooley","year":"2008","journal-title":"Developmental Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0365","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200308-1151OC","article-title":"Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis","volume":"170","author":"Cosgrove","year":"2004","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0370","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41467-019-09539-6","article-title":"Muscle functions as a connective tissue and source of extracellular matrix in planarians","volume":"10","author":"Cote","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0375","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000450919","article-title":"The role of epithelial-mesenchymal transition in chronic obstructive pulmonary disease","volume":"203","author":"Courtney","year":"2017","journal-title":"Cells, Tissues, Organs"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0380","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0092-8674(00)81460-9","article-title":"Thrombospondin-1 is a major activator of TGF-beta1 in vivo","volume":"93","author":"Crawford","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0385","first-page":"L159","article-title":"Pathobiology of pulmonary fibrosis","volume":"259","author":"Crouch","year":"1990","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0390","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/d41573-020-00180-3","article-title":"Integrin-targeted therapies branch out","volume":"19","author":"Cully","year":"2020","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0395","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1164\/rccm.200906-0964OC","article-title":"Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results","volume":"181","author":"Daniels","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0400","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1476-5381.2011.01247.x","article-title":"Novel therapeutic approaches for pulmonary fibrosis","volume":"163","author":"Datta","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0405","doi-asserted-by":"crossref","first-page":"L442","DOI":"10.1152\/ajplung.00026.2010","article-title":"Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis","volume":"299","author":"Degryse","year":"2010","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061299","article-title":"ER stress is involved in epithelial-to-mesenchymal transition of alveolar epithelial cells exposed to a hypoxic microenvironment","volume":"20","author":"Delbrel","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2020.05.006","article-title":"Fibroblasts: The arbiters of extracellular matrix remodeling","volume":"91-92","author":"DeLeon-Pennell","year":"2020","journal-title":"Matrix Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0420","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/thx.2005.042432","article-title":"Elevated MMP-12 protein levels in induced sputum from patients with COPD","volume":"61","author":"Demedts","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0425","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/bmj.332.7550.1142","article-title":"ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors","volume":"332","author":"Devereux","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0430","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.chest.2017.12.017","article-title":"TGF-beta signaling pathways in different compartments of the lower airways of patients with stable COPD","volume":"153","author":"Di Stefano","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0435","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0440","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaci.2009.02.032","article-title":"The outer wall of small airways is a major site of remodeling in fatal asthma","volume":"123","author":"Dolhnikoff","year":"2009","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acsptsci.9b00099","article-title":"IL-33 in chronic respiratory disease: from pre-clinical to clinical studies","volume":"3","author":"Donovan","year":"2020","journal-title":"ACS Pharmacology and Translational Science"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0450","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14451","article-title":"Pharmacological ablation of the airway smooth muscle layer-Mathematical predictions of functional improvement in asthma","volume":"8","author":"Donovan","year":"2020","journal-title":"Physiological Reports"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0455","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2222.2008.03157.x","article-title":"Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype","volume":"39","author":"Dougherty","year":"2009","journal-title":"Clinical and Experimental Allergy"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0460","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00424266","article-title":"Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha, -beta, and -gamma","volume":"281","author":"Duncan","year":"1989","journal-title":"Archives of Dermatological Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0465","doi-asserted-by":"crossref","first-page":"5214961","DOI":"10.1155\/2016\/5214961","article-title":"Neuron-glia interactions in neural plasticity: Contributions of neural extracellular matrix and perineuronal nets","volume":"2016","author":"Dzyubenko","year":"2016","journal-title":"Neural Plasticity"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0470","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s40265-018-1001-8","article-title":"Chronic obstructive pulmonary disease and lung cancer: Underlying pathophysiology and new therapeutic modalities","volume":"78","author":"Eapen","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8111986","article-title":"microRNAs are key regulators in chronic lung disease: Exploring the vital link between disease progression and lung cancer","volume":"8","author":"Eapen","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0480","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2147\/COPD.S208428","article-title":"Epithelial-mesenchymal transition is driven by transcriptional and post transcriptional modulations in COPD: implications for disease progression and new therapeutics","volume":"14","author":"Eapen","year":"2019","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0485","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41374-018-0146-0","article-title":"Heparin-binding epidermal growth factor (HB-EGF) drives EMT in patients with COPD: implications for disease pathogenesis and novel therapies","volume":"99","author":"Eapen","year":"2019","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0490","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMc1914437","article-title":"Update on the pathogenesis of COPD","volume":"381","author":"Eapen","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0495","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1164\/rccm.200308-1111OC","article-title":"Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis","volume":"169","author":"Ebina","year":"2004","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0500","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.mam.2008.08.001","article-title":"The ADAM metalloproteinases","volume":"29","author":"Edwards","year":"2008","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0505","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2466-14-120","article-title":"Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFbeta1","volume":"14","author":"Estany","year":"2014","journal-title":"BMC Pulmonary Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0510","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ar.20824","article-title":"Postnatal development of the lamina reticularis in primate airways","volume":"293","author":"Evans","year":"2010","journal-title":"Anatomical Record (Hoboken)"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0515","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jaci.2006.01.046","article-title":"Anti-IgE: lessons learned from effects on airway inflammation and asthma exacerbation","volume":"117","author":"Fahy","year":"2006","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0520","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI36136","article-title":"VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats","volume":"119","author":"Farkas","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0525","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(12)61144-1","article-title":"New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis","volume":"380","author":"Fernandez","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0530","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.jmedchem.9b01283","article-title":"Identification and optimization of mechanism-based fluoroallylamine inhibitors of lysyl oxidase-like 2\/3","volume":"62","author":"Findlay","year":"2019","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0535","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0540","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/reg2.97","article-title":"The diversity of myeloid immune cells shaping wound repair and fibrosis in the lung","volume":"5","author":"Florez-Sampedro","year":"2018","journal-title":"Regeneration (Oxford)"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0545","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/imr.12058","article-title":"The emerging role of microRNAs in regulating immune and inflammatory responses in the lung","volume":"253","author":"Foster","year":"2013","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0550","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/01.ATV.0000016045.93313.F2","article-title":"Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies","volume":"22","author":"Francis","year":"2002","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0555","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.4049\/jimmunol.0903476","article-title":"A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent","volume":"186","author":"Fritz","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0560","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.4049\/jimmunol.0900614","article-title":"Regulation of airway MUC5AC expression by IL-1beta and IL-17A; the NF-kappaB paradigm","volume":"183","author":"Fujisawa","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0565","first-page":"1","article-title":"Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis","author":"Gaikwad","year":"2020","journal-title":"Expert Review of Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/rr158","article-title":"A new direction in the pathogenesis of idiopathic pulmonary fibrosis?","volume":"3","author":"Gauldie","year":"2002","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0575","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90301","article-title":"miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways","volume":"1","author":"Ge","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0580","doi-asserted-by":"crossref","first-page":"9496","DOI":"10.1038\/srep09496","article-title":"Fibulin1C peptide induces cell attachment and extracellular matrix deposition in lung fibroblasts","volume":"5","author":"Ge","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0585","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ar.21094","article-title":"Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection","volume":"293","author":"Gill","year":"2010","journal-title":"Anatomical Record (Hoboken)"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0590","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1164\/rccm.201410-1874OC","article-title":"Calcium channel blocker reduces airway remodeling in severe asthma. A proof-of-concept study","volume":"191","author":"Girodet","year":"2015","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0595","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1165\/ajrcmb.16.6.9191468","article-title":"Myofibroblast involvement in the allergen-induced late response in mild atopic asthma","volume":"16","author":"Gizycki","year":"1997","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0600","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1183\/09031936.00135814","article-title":"Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition","volume":"45","author":"Gohy","year":"2015","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0605","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1014350","article-title":"Effect of bronchoconstriction on airway remodeling in asthma","volume":"364","author":"Grainge","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0610","first-page":"485","article-title":"Relationship between immunohistochemical assessment of bronchial mucosa microvascularization and clinical stage in asthma","volume":"53","author":"Grigoras","year":"2012","journal-title":"Romanian Journal of Morphology and Embryology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0615","first-page":"1421","article-title":"Semiquantitative 67Ga scintigraphy as an indicator of response to and prognosis after corticosteroid treatment in idiopathic interstitial pneumonia","volume":"46","author":"Grijm","year":"2005","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0620","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1073\/pnas.48.6.1014","article-title":"Collagenolytic activity in amphibian tissues: a tissue culture assay","volume":"48","author":"Gross","year":"1962","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0625","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1126\/science.282.5397.2261","article-title":"Requirement for IL-13 independently of IL-4 in experimental asthma","volume":"282","author":"Grunig","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0630","article-title":"BBT-877, a Potent Autotaxin Inhibitor in Clinical Development to Treat Idiopathic Pulmonary Fibrosis","volume":"54","author":"Gwanghee","year":"2019","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0635","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1972","article-title":"Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis","volume":"6","author":"Habermann","year":"2020","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0640","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/ACI.0b013e32834ec6eb","article-title":"Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma","volume":"12","author":"Hackett","year":"2012","journal-title":"Current Opinion in Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0645","doi-asserted-by":"crossref","first-page":"109540","DOI":"10.1016\/j.cellsig.2020.109540","article-title":"Lung epithelium damage in COPD - An unstoppable pathological event?","volume":"68","author":"Hadzic","year":"2020","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0650","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.4049\/jimmunol.168.12.6470","article-title":"TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells","volume":"168","author":"Hagimoto","year":"2002","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0655","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2017-000192","article-title":"Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis","volume":"4","author":"Hajari Case","year":"2017","journal-title":"BMJ Open Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2013.12.003","article-title":"Airway epithelial regulation of pulmonary immune homeostasis and inflammation","volume":"151","author":"Hallstrand","year":"2014","journal-title":"Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0665","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1183\/09031936.00165207","article-title":"Sex differences in physiological progression of idiopathic pulmonary fibrosis","volume":"31","author":"Han","year":"2008","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0670","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/268152a0","article-title":"Rigid control of synthesis of collagen types I and III by cells in culture","volume":"268","author":"Hance","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0675","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pharmthera.2007.11.002","article-title":"Understanding the mechanisms of viral induced asthma: new therapeutic directions","volume":"117","author":"Hansbro","year":"2008","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0680","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pharmthera.2003.10.007","article-title":"Role of atypical bacterial infection of the lung in predisposition\/protection of asthma","volume":"101","author":"Hansbro","year":"2004","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0685","doi-asserted-by":"crossref","first-page":"18214","DOI":"10.1074\/jbc.M114.548594","article-title":"Importance of mast cell Prss31\/transmembrane tryptase\/tryptase-gamma in lung function and experimental chronic obstructive pulmonary disease and colitis","volume":"289","author":"Hansbro","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0690","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1476-5381.2011.01219.x","article-title":"Cytokine\/anti-cytokine therapy - novel treatments for asthma?","volume":"163","author":"Hansbro","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0695","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imr.12543","article-title":"Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma","volume":"278","author":"Hansbro","year":"2017","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0700","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/13543784.2013.732997","article-title":"Th2 cytokine antagonists: potential treatments for severe asthma","volume":"22","author":"Hansbro","year":"2013","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0705","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12931-016-0394-8","article-title":"Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor","volume":"17","author":"Hansen","year":"2016","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0710","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1465-9921-11-165","article-title":"Variability in the precursor proteins of collagen I and III in different stages of COPD","volume":"11","author":"Harju","year":"2010","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0715","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pharmthera.2014.11.010","article-title":"Asthma is not only an airway disease, but also a vascular disease","volume":"148","author":"Harkness","year":"2015","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0720","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1378\/chest.127.3.965","article-title":"Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD","volume":"127","author":"Hashimoto","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0725","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/thoraxjnl-2014-205465","article-title":"Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia","volume":"70","author":"Hatchwell","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0730","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1155\/2006\/901417","article-title":"Mucin overproduction in chronic inflammatory lung disease","volume":"13","author":"Hauber","year":"2006","journal-title":"Canadian Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0735","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1126\/science.277.5334.2002","article-title":"Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice","volume":"277","author":"Hautamaki","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0740","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1164\/rccm.200501-088OC","article-title":"Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade","volume":"173","author":"Henderson","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0745","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/ajrccm.165.1.2105051","article-title":"A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model","volume":"165","author":"Henderson","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0750","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.bbadis.2012.10.005","article-title":"Integrin-mediated regulation of TGFbeta in fibrosis","volume":"1832","author":"Henderson","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0755","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125185","article-title":"Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis","volume":"4","author":"Herrera","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0760","doi-asserted-by":"crossref","first-page":"31","DOI":"10.29245\/2689-999X\/2019\/2.1149","article-title":"Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial\/fibroblastic cross-talk","volume":"3","author":"Hill","year":"2019","journal-title":"Journal of Lung Health and Diseases"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0765","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41419-019-1820-x","article-title":"Autophagy inhibition-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis","volume":"10","author":"Hill","year":"2019","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0770","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1165\/ajrcmb.23.3.3990","article-title":"Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype","volume":"23","author":"Hirst","year":"2000","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0775","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1183\/09031936.05.00077604","article-title":"Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation","volume":"25","author":"Hodge","year":"2005","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0780","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3109\/01902149009087890","article-title":"Leukotriene D4 (LTD4) induces mucus secretion from goblet cells in the guinea pig respiratory epithelium","volume":"16","author":"Hoffstein","year":"1990","journal-title":"Experimental Lung Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0785","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(04)16900-6","article-title":"Pathophysiology of airflow limitation in chronic obstructive pulmonary disease","volume":"364","author":"Hogg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0790","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1067\/mai.2003.25","article-title":"Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling","volume":"111","author":"Holgate","year":"2003","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0795","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.200706-805OC","article-title":"Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation","volume":"177","author":"Horan","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0800","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1067\/mai.2001.115626","article-title":"Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma","volume":"107","author":"Hoshino","year":"2001","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0805","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1067\/mai.2001.111928","article-title":"Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis","volume":"107","author":"Hoshino","year":"2001","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0810","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jaci.2004.04.041","article-title":"Synthetic responses in airway smooth muscle","volume":"114","author":"Howarth","year":"2004","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0815","first-page":"E2162","article-title":"Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers","volume":"113","author":"Hsia","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0820","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90443","article-title":"MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD","volume":"2","author":"Hsu","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0825","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223430","article-title":"Macrophage PPAR-gamma suppresses long-term lung fibrotic sequelae following acute influenza infection","volume":"14","author":"Huang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0830","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1081-1206(10)61170-2","article-title":"Effects of omalizumab and budesonide on markers of inflammation in human bronchial epithelial cells","volume":"95","author":"Huang","year":"2005","journal-title":"Annals of Allergy, Asthma & Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0835","doi-asserted-by":"crossref","unstructured":"Hubner, R.H., Gitter, W., El Mokhtari, N.E., Mathiak, M., Both, M., Bolte, H., Freitag-Wolf, S., & Bewig, B. (2008). Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques, 44, 507-511, 514-507.","DOI":"10.2144\/000112729"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0840","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1164\/rccm.201212-2297OC","article-title":"Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis","volume":"188","author":"Hung","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0845","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm.165.2.2106004","article-title":"Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis","volume":"165","author":"Hutyrova","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0850","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0855","doi-asserted-by":"crossref","first-page":"a004903","DOI":"10.1101\/cshperspect.a004903","article-title":"Overview of the matrisome--an inventory of extracellular matrix constituents and functions","volume":"4","author":"Hynes","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0860","doi-asserted-by":"crossref","first-page":"L325","DOI":"10.1152\/ajplung.00453.2010","article-title":"TGF-beta enhances deposition of perlecan from COPD airway smooth muscle","volume":"302","author":"Ichimaru","year":"2012","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0865","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36182-w","article-title":"Extracellular protein fibulin-7 and its C-terminal fragment have in vivo antiangiogenic activity","volume":"8","author":"Ikeuchi","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0870","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.13-2688","article-title":"Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis","volume":"146","author":"Jaffar","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0875","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1440-169X.2012.01364.x","article-title":"Induction of palate epithelial mesenchymal transition by transforming growth factor beta3 signaling","volume":"54","author":"Jalali","year":"2012","journal-title":"Development, Growth & Differentiation"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.mcp.0000146779.26339.d8","article-title":"Airway remodeling in asthma","volume":"11","author":"James","year":"2005","journal-title":"Current Opinion in Pulmonary Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0885","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1164\/rccm.201110-1849OC","article-title":"Airway smooth muscle hypertrophy and hyperplasia in asthma","volume":"185","author":"James","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0890","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1111\/bph.13573","article-title":"The inhibitor of semicarbazide-sensitive amine oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model","volume":"173","author":"Jarnicki","year":"2016","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0895","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2019.05.014","article-title":"Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons","volume":"202","author":"Jee","year":"2019","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0900","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13395-016-0089-3","article-title":"Laminin and Matrix metalloproteinase 11 regulate Fibronectin levels in the zebrafish myotendinous junction","volume":"6","author":"Jenkins","year":"2016","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0905","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(15)00048-X","article-title":"Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study","volume":"3","author":"Jenkins","year":"2015","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0910","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41385-020-00340-z","article-title":"Animal and translational models of SARS-CoV-2 infection and COVID-19","volume":"13","author":"Johansen","year":"2020","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0915","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1038\/s41467-020-18397-6","article-title":"Translational pharmacology of an inhaled small molecule alphavbeta6 integrin inhibitor for idiopathic pulmonary fibrosis","volume":"11","author":"John","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0920","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.2967\/jnumed.113.120592","article-title":"Preclinical SPECT\/CT imaging of alphavbeta6 integrins for molecular stratification of idiopathic pulmonary fibrosis","volume":"54","author":"John","year":"2013","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0925","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaci.2003.12.312","article-title":"Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism","volume":"113","author":"Johnson","year":"2004","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0930","doi-asserted-by":"crossref","first-page":"L658","DOI":"10.1152\/ajplung.00286.2014","article-title":"Pericytes contribute to airway remodeling in a mouse model of chronic allergic asthma","volume":"308","author":"Johnson","year":"2015","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0935","article-title":"Chronic respiratory aeroallergen exposure in mice induces epithelial-mesenchymal transition in the large airways","volume":"6","author":"Johnson","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0940","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1164\/ajrccm.162.6.9909111","article-title":"The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture: the effect of beclomethasone","volume":"162","author":"Johnson","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0945","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1164\/ajrccm.164.3.2010109","article-title":"Airway smooth muscle cell proliferation is increased in asthma","volume":"164","author":"Johnson","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0950","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/dvdy.24541","article-title":"Epithelial-mesenchymal transition, a spectrum of states: Role in lung development, homeostasis, and disease","volume":"247","author":"Jolly","year":"2018","journal-title":"Developmental Dynamics"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0955","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/resp.12908","article-title":"Animal models of COPD: What do they tell us?","volume":"22","author":"Jones","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0960","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10735-006-9018-9","article-title":"Localization of precursor proteins and mRNA of type I and III collagens in usual interstitial pneumonia and sarcoidosis","volume":"36","author":"Kaarteenaho-Wiik","year":"2005","journal-title":"Journal of Molecular Histology"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2021.107839_bb0965","first-page":"1","article-title":"Collagen fibril formation","volume":"316","author":"Kadler","year":"1996","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0970","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0954-6111(03)00136-7","article-title":"Airway inflammation and basement membrane tenascin in newly diagnosed atopic and nonatopic asthma","volume":"97","author":"Karjalainen","year":"2003","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0975","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jhep.2015.08.014","article-title":"Collagen and tissue turnover as a function of age: Implications for fibrosis","volume":"64","author":"Karsdal","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0980","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/adt.2012.474","article-title":"Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure","volume":"11","author":"Karsdal","year":"2013","journal-title":"Assay and Drug Development Technologies"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0985","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/thorax.57.3.242","article-title":"Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma","volume":"57","author":"Kasahara","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0990","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fmed.2017.00154","article-title":"Genetics in idiopathic pulmonary fibrosis pathogenesis, prognosis, and treatment","volume":"4","author":"Kaur","year":"2017","journal-title":"Frontiers in Medicine (Lausanne)"},{"key":"10.1016\/j.pharmthera.2021.107839_bb0995","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.4049\/jimmunol.1800671","article-title":"Influenza A virus infection causes chronic lung disease linked to sites of active viral RNA remnants","volume":"201","author":"Keeler","year":"2018","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1000","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/mi.2011.55","article-title":"Pulmonary-intestinal cross-talk in mucosal inflammatory disease","volume":"5","author":"Keely","year":"2012","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13059-015-0676-3","article-title":"The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family","volume":"16","author":"Kelwick","year":"2015","journal-title":"Genome Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1010","article-title":"Phenotypic and functional translation of IL33 genetics in asthma","author":"Ketelaar","year":"2020","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1015","first-page":"194","article-title":"The role of TGF-beta in pulmonary fibrosis","volume":"157","author":"Khalil","year":"1991","journal-title":"Ciba Foundation Symposium"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00663-2018","article-title":"Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis","volume":"53","author":"Khalil","year":"2019","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/jamp.2018.1507","article-title":"A randomized, double-blinded, placebo-controlled, dose-escalation phase 1 study of aerosolized pirfenidone delivered via the PARI investigational eFlow nebulizer in volunteers and patients with idiopathic pulmonary fibrosis","volume":"33","author":"Khoo","year":"2020","journal-title":"Journal of Aerosol Medicine and Pulmonary Drug Delivery"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jemt.20564","article-title":"Mammalian collagen IV","volume":"71","author":"Khoshnoodi","year":"2008","journal-title":"Microscopy Research and Technique"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yexcr.2014.11.020","article-title":"Lysophospholipid receptors in drug discovery","volume":"333","author":"Kihara","year":"2015","journal-title":"Experimental Cell Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4196\/kjpp.2015.19.1.65","article-title":"Airway smooth muscle sensitivity to methacholine in precision-cut lung slices (PCLS) from ovalbumin-induced asthmatic mice","volume":"19","author":"Kim","year":"2015","journal-title":"The Korean Journal of Physiology and Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2021.107839_bb1045","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaci.2016.04.038","article-title":"MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2","volume":"139","author":"Kim","year":"2016","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1050","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaci.2016.04.038","article-title":"MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase-mediated suppression of histone deacetylase 2","volume":"139","author":"Kim","year":"2017","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11033-010-0088-0","article-title":"The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin","volume":"38","author":"Kim","year":"2011","journal-title":"Molecular Biology Reports"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1060","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1065","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1164\/rccm.201011-1874OC","article-title":"BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis","volume":"184","author":"King","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1070","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1007\/s00018-009-0096-1","article-title":"Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans","volume":"66","author":"Kirn-Safran","year":"2009","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1075","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1172\/JCI45589","article-title":"Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin alphavbeta8-mediated activation of TGF-beta","volume":"121","author":"Kitamura","year":"2011","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1080","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1096\/fj.10-154435","article-title":"EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK\/Erk 1\/2-dependent signaling","volume":"24","author":"Kohan","year":"2010","journal-title":"The FASEB Journal"},{"issue":"9","key":"10.1016\/j.pharmthera.2021.107839_bb1085","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1164\/rccm.201909-1818OC","article-title":"Thrombomodulin alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Randomized, Double-blind, Placebo-controlled Trial","volume":"201","author":"Kondoh","year":"2020","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1090","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1164\/rccm.200802-313OC","article-title":"Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis","volume":"178","author":"Korfei","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1095","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1309\/JC477FAEL1YKV54W","article-title":"Enhanced bronchial expression of extracellular matrix proteins in chronic obstructive pulmonary disease","volume":"126","author":"Kranenburg","year":"2006","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1100","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1165\/ajrcmb.23.4.4115","article-title":"Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle","volume":"23","author":"Krymskaya","year":"2000","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1105","doi-asserted-by":"crossref","first-page":"L1147","DOI":"10.1152\/ajplung.00098.2003","article-title":"Coordinate expression of fibulin-5\/DANCE and elastin during lung injury repair","volume":"285","author":"Kuang","year":"2003","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1110","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1165\/rcmb.2015-0166PS","article-title":"Matrix remodeling in pulmonary fibrosis and emphysema","volume":"54","author":"Kulkarni","year":"2016","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1115","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1440-1843.2010.01918.x","article-title":"Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo","volume":"16","author":"Kuo","year":"2011","journal-title":"Respirology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1120","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1164\/ajrccm\/148.5.1220","article-title":"Small airways dimensions in asthma and in chronic obstructive pulmonary disease","volume":"148","author":"Kuwano","year":"1993","journal-title":"The American Review of Respiratory Disease"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1465-9921-4-6","article-title":"Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in Idiopathic Pulmonary Fibrosis","volume":"4","author":"Latsi","year":"2003","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013360","article-title":"Fibulin-1 is increased in asthma--a novel mediator of airway remodeling?","volume":"5","author":"Lau","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1135","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/thx.2004.026336","article-title":"Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF","volume":"59","author":"Lawson","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1140","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1145","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI200112067","article-title":"Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3)","volume":"108","author":"Leco","year":"2001","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1150","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1165\/rcmb.2006-0012OC","article-title":"Neutrophil-derived elastase induces TGF-beta1 secretion in human airway smooth muscle via NF-kappaB pathway","volume":"35","author":"Lee","year":"2006","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4137\/BMI.S9415","article-title":"Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis","volume":"7","author":"Leeming","year":"2012","journal-title":"Biomarker Insights"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1160","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/rccm.200206-509OC","article-title":"Effects of montelukast and budesonide on airway responses and airway inflammation in asthma","volume":"166","author":"Leigh","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1165","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaci.2004.11.051","article-title":"Airway fibroblasts exhibit a synthetic phenotype in severe asthma","volume":"115","author":"Lewis","year":"2005","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1170","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12885-020-6686-x","article-title":"Elastin is a key factor of tumor development in colorectal cancer","volume":"20","author":"Li","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1175","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1259\/bjr\/85580974","article-title":"Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infection","volume":"85","author":"Li","year":"2012","journal-title":"The British Journal of Radiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1164\/ajrccm.156.1.9607066","article-title":"Increased vascularity of the bronchial mucosa in mild asthma","volume":"156","author":"Li","year":"1997","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1185","first-page":"1923","article-title":"Idiopathic pulmonary fibrosis in relation to gene polymorphisms of transforming growth factor-beta1 and plasminogen activator inhibitor 1","volume":"124","author":"Li","year":"2011","journal-title":"Chinese Medical Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1190","first-page":"127","article-title":"Reticular basement membrane in asthma and COPD: similar thickness, yet different composition","volume":"4","author":"Liesker","year":"2009","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1195","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.ASN.0000042168.43665.9B","article-title":"Therapeutic role of TGF-beta-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation","volume":"14","author":"Ling","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1016\/j.pharmthera.2021.107839_bb1200","doi-asserted-by":"crossref","first-page":"7718","DOI":"10.1096\/fj.201901779R","article-title":"Platelet activating factor receptor acts to limit colitis-induced liver inflammation","volume":"34","author":"Liu","year":"2020","journal-title":"The FASEB Journal"},{"issue":"16","key":"10.1016\/j.pharmthera.2021.107839_bb1205","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124529","article-title":"Fibulin-1c regulates transforming growth factor-\u03b2 activation in pulmonary tissue fibrosis","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1210","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86380","article-title":"Fibulin-1 regulates the pathogenesis of tissue remodeling in respiratory diseases","volume":"1","author":"Liu","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1215","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/path.4979","article-title":"Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1c","volume":"243","author":"Liu","year":"2017","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1220","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41385-019-0163-3","article-title":"Platelet activating factor receptor regulates colitis-induced pulmonary inflammation through the NLRP3 inflammasome","volume":"12","author":"Liu","year":"2019","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1225","first-page":"2690","article-title":"Association of ENA-78, IP-10 and VEGF gene polymorphism with idiopathic pulmonary fibrosis","volume":"89","author":"Liu","year":"2009","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1230","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1465-9921-12-48","article-title":"Tenascin-C and alpha-smooth muscle actin positive cells are increased in the large airways in patients with COPD","volume":"12","author":"Lofdahl","year":"2011","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12915-016-0281-2","article-title":"Type IV collagen drives alveolar epithelial-endothelial association and the morphogenetic movements of septation","volume":"14","author":"Loscertales","year":"2016","journal-title":"BMC Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1240","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1165\/ajrcmb.22.6.3927","article-title":"Interleukin-9 upregulates mucus expression in the airways","volume":"22","author":"Louahed","year":"2000","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1245","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00778-2019","article-title":"Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis","volume":"54","author":"Lu","year":"2019","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1250","first-page":"A7468","article-title":"MMI-0100, a Novel MAPKAP Kinase II (MK2) Inhibitor, Delivered Via Inhalation, Displays an Excellent Safety and Tolerability Profile in Three Phase 1 Clinical Trials","volume":"197","author":"Luber","year":"2018","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1255","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00259-019-04586-z","article-title":"Clinical quantification of the integrin alphavbeta6 by [(18)F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)","volume":"47","author":"Lukey","year":"2020","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1260","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1159\/000489144","article-title":"Fibulin-3 attenuates phosphate-induced vascular smooth muscle cell calcification by inhibition of oxidative stress","volume":"46","author":"Luong","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1265","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/thx.2010.135947","article-title":"Low-dose oral interferon alpha possibly retards the progression of idiopathic pulmonary fibrosis and alleviates associated cough in some patients","volume":"66","author":"Lutherer","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1270","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/bjsm.36.5.315","article-title":"Tendon healing: can it be optimised?","volume":"36","author":"Maffulli","year":"2002","journal-title":"British Journal of Sports Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1275","doi-asserted-by":"crossref","first-page":"1902442","DOI":"10.1183\/13993003.02442-2019","article-title":"Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis","volume":"57","author":"Maher","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1280","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2019-000422","article-title":"Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)","volume":"6","author":"Maher","year":"2019","journal-title":"BMJ Open Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1285","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S2213-2600(17)30430-7","article-title":"An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study","volume":"5","author":"Maher","year":"2017","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1290","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2018-000325","article-title":"Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK(R)trial","volume":"5","author":"Maher","year":"2018","journal-title":"BMJ Open Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1295","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2466-11-33","article-title":"Static and dynamic mechanics of the murine lung after intratracheal bleomycin","volume":"11","author":"Manali","year":"2011","journal-title":"BMC Pulmonary Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1300","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1016\/S0021-9258(19)34123-7","article-title":"Analysis of glycosaminoglycan substitution in decorin by site-directed mutagenesis","volume":"265","author":"Mann","year":"1990","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1305","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1183\/16000617.0050-2015","article-title":"Smoking and interstitial lung diseases","volume":"24","author":"Margaritopoulos","year":"2015","journal-title":"European Respiratory Review"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1310","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1164\/ajrccm.164.supplement_2.2106065","article-title":"Angiogenesis and remodeling of airway vasculature in chronic inflammation","volume":"164","author":"McDonald","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1315","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1183\/09031936.00060708","article-title":"MMP expression and abnormal lung permeability are important determinants of outcome in IPF","volume":"33","author":"McKeown","year":"2009","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1320","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.4049\/jimmunol.174.9.5774","article-title":"Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway","volume":"174","author":"McMillan","year":"2005","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1325","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/157339806776843085","article-title":"The epithelial cell in lung health and emphysema pathogenesis","volume":"2","author":"Mercer","year":"2006","journal-title":"Current Respiratory Medicine Reviews"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1330","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1465-9921-9-41","article-title":"Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease","volume":"9","author":"Merrilees","year":"2008","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1335","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12931-018-0927-4","article-title":"MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease","volume":"19","author":"Milara","year":"2018","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1340","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/all.13546","article-title":"Mucin 1 deficiency mediates corticosteroid insensitivity in asthma","volume":"74","author":"Milara","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1345","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008074","article-title":"Selective targeting of TGF-beta activation to treat fibroinflammatory airway disease","volume":"6","author":"Minagawa","year":"2014","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1350","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11547-011-0740-3","article-title":"Post-ARDS pulmonary fibrosis in patients with H1N1 pneumonia: role of follow-up CT","volume":"117","author":"Mineo","year":"2012","journal-title":"La Radiologia Medica"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113848","article-title":"The role of microRNA in the airway surface liquid homeostasis","volume":"21","author":"Mitash","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1360","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pharmthera.2016.06.009","article-title":"Biologics and the lung: TSLP and other epithelial cell-derived cytokines in asthma","volume":"169","author":"Mitchell","year":"2017","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1365","doi-asserted-by":"crossref","first-page":"C995","DOI":"10.1152\/ajpcell.1993.264.4.C995","article-title":"Expression of vascular permeability factor\/vascular endothelial growth factor in normal rat tissues","volume":"264","author":"Monacci","year":"1993","journal-title":"The American Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1370","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0002-9440(10)63658-9","article-title":"Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6\/gp130-mediated cell signaling and proliferation","volume":"163","author":"Moodley","year":"2003","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1375","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1165\/rcmb.2006-0121OC","article-title":"Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis","volume":"35","author":"Mora","year":"2006","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.mcp.0000198064.27586.37","article-title":"Mucus and MUC in asthma","volume":"12","author":"Morcillo","year":"2006","journal-title":"Current Opinion in Pulmonary Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1385","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021873","article-title":"TGF-beta and the TGF-beta family: Context-dependent roles in cell and tissue physiology","volume":"8","author":"Morikawa","year":"2016","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1390","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature01413","article-title":"Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema","volume":"422","author":"Morris","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1395","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1513\/pats.200908-087RM","article-title":"Transforming growth factor-beta signaling across ages: from distorted lung development to chronic obstructive pulmonary disease","volume":"6","author":"Morty","year":"2009","journal-title":"Proceedings of the American Thoracic Society"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1400","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201810-1855OC","article-title":"Defective fibrillar collagen organization by fibroblasts contributes to airway remodeling in asthma","volume":"200","author":"Mostaco-Guidolin","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1405","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1465-9921-7-32","article-title":"Lung fibroblasts from patients with emphysema show markers of senescence in vitro","volume":"7","author":"Muller","year":"2006","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1410","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0092-8674(00)80545-0","article-title":"The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis","volume":"96","author":"Munger","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1415","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1164\/rccm.200708-1291OC","article-title":"An essential role for fibronectin extra type III domain A in pulmonary fibrosis","volume":"177","author":"Muro","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1420","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/gb-2011-12-11-233","article-title":"Tissue inhibitors of metalloproteinases","volume":"12","author":"Murphy","year":"2011","journal-title":"Genome Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1425","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1165\/rcmb.2013-0342OC","article-title":"Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model","volume":"50","author":"Murray","year":"2014","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1430","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.matbio.2012.11.008","article-title":"Towards definition of an ECM parts list: an advance on GO categories","volume":"31","author":"Naba","year":"2012","journal-title":"Matrix Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1435","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/rr43","article-title":"Role of epidermal growth factor receptor activation in regulating mucin synthesis","volume":"2","author":"Nadel","year":"2001","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1440","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1445","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1002\/eji.200636271","article-title":"Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse","volume":"36","author":"Nakahara","year":"2006","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1450","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/415171a","article-title":"Fibulin-5\/DANCE is essential for elastogenesis in vivo","volume":"415","author":"Nakamura","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1455","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0140-6736(00)02584-8","article-title":"Airway remodelling in cough-variant asthma","volume":"356","author":"Niimi","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1460","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/rccm.200211-1268OC","article-title":"Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma","volume":"168","author":"Niimi","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065580","article-title":"Bronchoconstriction Induces TGF-beta Release and Airway Remodelling in Guinea Pig Lung Slices","volume":"8","author":"Oenema","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1470","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1165\/ajrcmb.15.3.8810646","article-title":"Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation","volume":"15","author":"Ohno","year":"1996","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1475","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejphar.2008.06.046","article-title":"Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis","volume":"590","author":"Oku","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1480","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1164\/ajrccm.162.6.2001041","article-title":"Epithelial desquamation in asthma: artifact or pathology?","volume":"162","author":"Ordonez","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1485","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12931-019-1118-7","article-title":"Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort","volume":"20","author":"Organ","year":"2019","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1490","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/thx.54.4.289","article-title":"Vascularity in asthmatic airways: relation to inhaled steroid dose","volume":"54","author":"Orsida","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1495","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02538-2016","article-title":"miR-146a-5p plays an essential role in the aberrant epithelial-fibroblast cross-talk in COPD","volume":"49","author":"Osei","year":"2017","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1500","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.chest.2018.08.1058","article-title":"Randomized, double-blind, placebo-controlled, phase 2 trial of BMS-986020, a lysophosphatidic acid receptor antagonist for the treatment of idiopathic pulmonary fibrosis","volume":"154","author":"Palmer","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1505","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1242\/jcs.00059","article-title":"Fibronectin at a glance","volume":"115","author":"Pankov","year":"2002","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1510","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1398-9995.2010.02505.x","article-title":"Viruses and bacteria in acute asthma exacerbations--a GA(2) LEN-DARE systematic review","volume":"66","author":"Papadopoulos","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1515","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.matbio.2014.02.004","article-title":"Fibulin-4 and fibulin-5 in elastogenesis and beyond: Insights from mouse and human studies","volume":"37","author":"Papke","year":"2014","journal-title":"Matrix Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1520","first-page":"589","article-title":"The functional consequences of airway remodeling in asthma","volume":"52","author":"Pare","year":"1997","journal-title":"Monaldi Archives for Chest Disease"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1525","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072269","article-title":"Alveolar epithelial type ii cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis","volume":"21","author":"Parimon","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1530","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1164\/rccm.201704-0784OC","article-title":"A phase 2 randomized controlled study of tralokinumab in subjects with idiopathic pulmonary fibrosis","volume":"197","author":"Parker","year":"2018","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1535","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1369\/jhc.6A6969.2006","article-title":"Interstitial and vascular type V collagen morphologic disorganization in usual interstitial pneumonia","volume":"54","author":"Parra","year":"2006","journal-title":"The Journal of Histochemistry and Cytochemistry"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2021.107839_bb1540","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2249.2008.03715.x","article-title":"Allergy and the lung","volume":"153","author":"Passalacqua","year":"2008","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1545","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jaci.2009.02.034","article-title":"Airway inflammation in patients with asthma with high-fixed or low-fixed plus as-needed budesonide\/formoterol","volume":"123","author":"Pavord","year":"2009","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1550","doi-asserted-by":"crossref","first-page":"32258","DOI":"10.1074\/jbc.M204862200","article-title":"Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor\/Ras\/Raf\/extracellular signal-regulated kinase cascade and Sp1","volume":"277","author":"Perrais","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1555","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.mehy.2013.06.005","article-title":"Tenascin-X, collagen, and Ehlers-Danlos syndrome: tenascin-X gene defects can protect against adverse cardiovascular events","volume":"81","author":"Petersen","year":"2013","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1560","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/hy0202.103268","article-title":"Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts","volume":"39","author":"Petrov","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1565","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1165\/rcmb.2018-0313OC","article-title":"Defining the activated fibroblast population in lung fibrosis using single-cell sequencing","volume":"61","author":"Peyser","year":"2019","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1570","doi-asserted-by":"crossref","first-page":"286S","DOI":"10.1378\/chest.122.6_suppl.286S","article-title":"The myofibroblast in pulmonary fibrosis","volume":"122","author":"Phan","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1575","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.170.3.655","article-title":"Tumor necrosis factor\/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis","volume":"170","author":"Piguet","year":"1989","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1580","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/COPD.S52478","article-title":"Central airways remodeling in COPD patients","volume":"9","author":"Pini","year":"2014","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1585","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1034\/j.1399-3003.1999.14a04.x","article-title":"Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial","volume":"14","author":"Pizzichini","year":"1999","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1590","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0062-2017","article-title":"Physiology of the lung in idiopathic pulmonary fibrosis","volume":"27","author":"Plantier","year":"2018","journal-title":"European Respiratory Review"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1595","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1378\/chest.127.1.266","article-title":"Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis","volume":"127","author":"Plataki","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1600","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ajpath.2016.12.012","article-title":"Epigenetic and transcriptomic regulation of lung repair during recovery from influenza infection","volume":"187","author":"Pociask","year":"2017","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1605","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/01902148.2012.658595","article-title":"Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice","volume":"38","author":"Polosukhin","year":"2012","journal-title":"Experimental Lung Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1610","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/art.24620","article-title":"Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen","volume":"60","author":"Ponticos","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1615","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s41030-019-0096-8","article-title":"A phase 1b study of vismodegib with pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"5","author":"Prasse","year":"2019","journal-title":"Pulmonary Therapy"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1620","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","article-title":"Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells","volume":"183","author":"Prefontaine","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1625","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1465-9921-10-107","article-title":"Pulmonary fibrosis induced by H5N1 viral infection in mice","volume":"10","author":"Qiao","year":"2009","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1630","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.3892\/mmr.2017.6863","article-title":"Silencing of beta1 integrin regulates airway remodeling by regulating the transcription of SOCEassociated genes in asthmatic mice","volume":"16","author":"Qiu","year":"2017","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1635","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051313","article-title":"Metalloproteinases and their inhibitors: Potential for the development of new therapeutics","volume":"9","author":"Raeeszadeh-Sarmazdeh","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1640","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-158-9-201305070-00003","article-title":"Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial","volume":"158","author":"Raghu","year":"2013","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1645","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa030511","article-title":"A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis","volume":"350","author":"Raghu","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1650","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-2600(16)30421-0","article-title":"Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial","volume":"5","author":"Raghu","year":"2017","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1655","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.200709-1446OC","article-title":"Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial","volume":"178","author":"Raghu","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1660","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01130-2018","article-title":"SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)","volume":"52","author":"Raghu","year":"2018","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1665","doi-asserted-by":"crossref","first-page":"16986","DOI":"10.1074\/jbc.M000528200","article-title":"Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells","volume":"275","author":"Rahimi","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1670","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2353\/ajpath.2009.080212","article-title":"Failure of pelvic organ support in mice deficient in fibulin-3","volume":"174","author":"Rahn","year":"2009","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1675","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1165\/rcmb.2014-0445OC","article-title":"Novel mechanisms for the antifibrotic action of nintedanib","volume":"54","author":"Rangarajan","year":"2016","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1680","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nbt1114-1069","article-title":"Landmark approvals in idiopathic pulmonary fibrosis","volume":"32","author":"Ratner","year":"2014","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1685","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/thx.2009.134106","article-title":"Airway remodelling and its relationship to inflammation in cystic fibrosis","volume":"66","author":"Regamey","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1690","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1165\/rcmb.2019-0069OC","article-title":"Blocking notch3 signaling abolishes MUC5AC production in airway epithelial cells from individuals with asthma","volume":"62","author":"Reid","year":"2020","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1695","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2017.12.009","article-title":"Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches","volume":"185","author":"Reid","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1700","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004978","article-title":"The collagen family","volume":"3","author":"Ricard-Blum","year":"2011","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1705","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1710","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-2600(19)30262-0","article-title":"Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial","volume":"8","author":"Richeldi","year":"2020","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1715","doi-asserted-by":"crossref","first-page":"15337","DOI":"10.1523\/JNEUROSCI.3467-10.2010","article-title":"Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?","volume":"30","author":"Rivera","year":"2010","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1720","first-page":"E1475","article-title":"Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition","volume":"108","author":"Rock","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1725","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1021\/jm900431g","article-title":"Design, synthesis, and evaluation of indolinones as triple angiokinase inhibitors and the discovery of a highly specific 6-methoxycarbonyl-substituted indolinone (BIBF 1120)","volume":"52","author":"Roth","year":"2009","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1730","doi-asserted-by":"crossref","first-page":"51323","DOI":"10.1074\/jbc.M409565200","article-title":"ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage","volume":"279","author":"Roy","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1735","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2013.04.012","article-title":"IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma","volume":"132","author":"Saglani","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1740","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1183\/09031936.06.00056405","article-title":"Ultrastructure of the reticular basement membrane in asthmatic adults, children and infants","volume":"28","author":"Saglani","year":"2006","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1745","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119717","article-title":"Vitronectin expression in the airways of subjects with asthma and chronic obstructive pulmonary disease","volume":"10","author":"Salazar-Pelaez","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1750","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/2211-5463.12455","article-title":"Elastin molecular aging promotes MDA-MB-231 breast cancer cell invasiveness","volume":"8","author":"Salesse","year":"2018","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1755","article-title":"Epithelial(-)mesenchymal transition in the pathogenesis of idiopathic pulmonary fibrosis","volume":"55","author":"Salton","year":"2019","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1760","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/thorax.56.12.902","article-title":"Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects","volume":"56","author":"Salvato","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084934","article-title":"MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis--validation of two novel biomarker assays","volume":"8","author":"Sand","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1770","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12931-016-0440-6","article-title":"High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study","volume":"17","author":"Sand","year":"2016","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1775","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.clinbiochem.2016.09.003","article-title":"Characterization of serological neo-epitope biomarkers reflecting collagen remodeling in clinically stable chronic obstructive pulmonary disease","volume":"49","author":"Sand","year":"2016","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1780","doi-asserted-by":"crossref","first-page":"819","DOI":"10.15252\/msb.20156123","article-title":"Time- and compartment-resolved proteome profiling of the extracellular niche in lung injury and repair","volume":"11","author":"Schiller","year":"2015","journal-title":"Molecular Systems Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1785","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.chest.2018.06.028","article-title":"Collagen degradation and formation are elevated in exacerbated COPD compared with stable disease","volume":"154","author":"Schumann","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1790","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1183\/13993003.00398-2016","article-title":"Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis","volume":"48","author":"Selman","year":"2016","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1795","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109482","article-title":"The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis","volume":"66","author":"Selman","year":"2020","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1800","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0002-9440(10)63589-4","article-title":"Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice","volume":"163","author":"Shapiro","year":"2003","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1805","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1091\/mbc.E14-10-1463","article-title":"ADAM10 controls collagen signaling and cell migration on collagen by shedding the ectodomain of discoidin domain receptor 1 (DDR1)","volume":"26","author":"Shitomi","year":"2015","journal-title":"Molecular Biology of the Cell"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1810","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/MCB.01876-07","article-title":"Fibulin-2 is dispensable for mouse development and elastic fiber formation","volume":"28","author":"Sicot","year":"2008","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1815","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI119590","article-title":"Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung","volume":"100","author":"Sime","year":"1997","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1820","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.2003.009860","article-title":"Angiogenic cytokines in patients with idiopathic interstitial pneumonia","volume":"59","author":"Simler","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1825","doi-asserted-by":"crossref","DOI":"10.1042\/CS20140654","article-title":"A short term mouse model that reproduces the immunopathological features of rhinovirus induced exacerbation of COPD","author":"Singanayagam","year":"2015","journal-title":"Clinical Science (London, England)"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1830","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jaci.2008.02.017","article-title":"Expression of smooth muscle and extracellular matrix proteins in relation to airway function in asthma","volume":"121","author":"Slats","year":"2008","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1835","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2821","article-title":"Regulation of cell signalling by uPAR","volume":"11","author":"Smith","year":"2010","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1840","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/17476348.2019.1623028","article-title":"Pulmonary fibrosis: a disease of alveolar collapse and collagen deposition","volume":"13","author":"Snijder","year":"2019","journal-title":"Expert Review of Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1845","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1440-1843.2010.01808.x","article-title":"Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease","volume":"15","author":"Sohal","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1850","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1513\/AnnalsATS.201705-387LE","article-title":"Epithelial mesenchymal transition in chronic obstructive pulmonary disease, a precursor for epithelial cancers: understanding and translation to early therapy","volume":"14","author":"Sohal","year":"2017","journal-title":"Annals of the American Thoracic Society"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1855","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1465-9921-12-130","article-title":"Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease","volume":"12","author":"Sohal","year":"2011","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1860","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/COPD.S63911","article-title":"A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial-mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study","volume":"9","author":"Sohal","year":"2014","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1865","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/thoraxjnl-2014-205582","article-title":"Importance of epithelial mesenchymal transition (EMT) in COPD and asthma","volume":"69","author":"Sohal","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1870","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039736","article-title":"Vessel-associated transforming growth factor-beta1 (TGF-beta1) is increased in the bronchial reticular basement membrane in COPD and normal smokers","volume":"7","author":"Soltani","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1875","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2147\/COPD.S113176","article-title":"Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD","volume":"11","author":"Soltani","year":"2016","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1880","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.stem.2018.02.009","article-title":"Vascular tissue engineering: progress, challenges, and clinical promise","volume":"22","author":"Song","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1885","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/mi.2012.99","article-title":"Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease","volume":"6","author":"Starkey","year":"2013","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1890","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.chest.2016.08.1440","article-title":"Systemic biomarkers of collagen and elastin turnover are associated with clinically relevant outcomes in COPD","volume":"151","author":"Stolz","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1895","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1172\/JCI58815","article-title":"The alphavbeta6 integrin modulates airway hyperresponsiveness in mice by regulating intraepithelial mast cells","volume":"122","author":"Sugimoto","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1900","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pupt.2009.04.002","article-title":"N-acetyl-L-cysteine inhibits TGF-beta1-induced profibrotic responses in fibroblasts","volume":"22","author":"Sugiura","year":"2009","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1905","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jcla.20069","article-title":"Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Sumi","year":"2005","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1910","article-title":"The RIFF study (cohort A): A phase ii, randomized, double-blind, placebo-controlled trial of lebrikizumab as monotherapy in patients with idiopathic pulmonary fibrosis","author":"Swigris","year":"2018","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1915","first-page":"213","article-title":"Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis","volume":"119","author":"KimWei","year":"2009","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1920","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nm1685","article-title":"The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak","volume":"14","author":"Tager","year":"2008","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1925","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/gb-2007-8-5-215","article-title":"The integrins","volume":"8","author":"Takada","year":"2007","journal-title":"Genome Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1930","article-title":"Phase 2, multi-center, open label, single-arm study of TAS-115, a novel multi-kinase inhibitor in patients with idiopathic pulmonary fibrosis","volume":"54","author":"Takashi","year":"2019","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1935","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1164\/ajrccm.163.6.9908135","article-title":"Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD)","volume":"163","author":"Takizawa","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1940","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JCM.41.6.2633-2640.2003","article-title":"Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis","volume":"41","author":"Tang","year":"2003","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1945","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/all.14060","article-title":"MiR-31-5p: A shared regulator of chronic mucus hypersecretion in asthma and chronic obstructive pulmonary disease","volume":"75","author":"Tasena","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1950","first-page":"S31","article-title":"Reducing affinity of alphavbeta8 interactions with latent TGFbeta: dialling down fibrosis","volume":"3","author":"Tatler","year":"2015","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1955","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.4049\/jimmunol.1003507","article-title":"Integrin alphavbeta5-mediated TGF-beta activation by airway smooth muscle cells in asthma","volume":"187","author":"Tatler","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1960","article-title":"Antagonism of miR-328 increases the antimicrobial function of macrophages and neutrophils and rapid clearance of non-typeable Haemophilus influenzae (NTHi) from infected lung","volume":"11","author":"Tay","year":"2015","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1965","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2174\/1566524015666150921105339","article-title":"Integrins as therapeutic targets for respiratory diseases","volume":"15","author":"Teoh","year":"2015","journal-title":"Current Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1970","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1513\/pats.2306016","article-title":"From mucins to mucus: toward a more coherent understanding of this essential barrier","volume":"1","author":"Thornton","year":"2004","journal-title":"Proceedings of the American Thoracic Society"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1975","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/74725","article-title":"Angiopoietin-1 protects the adult vasculature against plasma leakage","volume":"6","author":"Thurston","year":"2000","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1980","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1242\/dmm.030114","article-title":"Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis","volume":"10","author":"Tjin","year":"2017","journal-title":"Disease Models & Mechanisms"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1985","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.19.3.036005","article-title":"Quantification of collagen I in airway tissues using second harmonic generation","volume":"19","author":"Tjin","year":"2014","journal-title":"Journal of Biomedical Optics"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1990","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev.physiol.010908.163227","article-title":"Noncontractile functions of airway smooth muscle cells in asthma","volume":"71","author":"Tliba","year":"2009","journal-title":"Annual Review of Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb1995","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12890-020-1103-4","article-title":"Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort","volume":"20","author":"Todd","year":"2020","journal-title":"BMC Pulmonary Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2000","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.rmed.2009.03.018","article-title":"Budesonide\/formoterol effects on metalloproteolytic balance in TGFbeta-activated human lung fibroblasts","volume":"103","author":"Todorova","year":"2009","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2005","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1165\/rcmb.2011-0224OC","article-title":"Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosis","volume":"46","author":"Torres-Gonzalez","year":"2012","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2010","article-title":"Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity","author":"Townsend","year":"2021","journal-title":"Annals of the American Thoracic Society"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2015","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1084\/jem.20070956","article-title":"Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma","volume":"204","author":"Trian","year":"2007","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092787","article-title":"Extracellular interactions between fibulins and transforming growth factor (TGF)-beta in physiological and pathological conditions","volume":"19","author":"Tsuda","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2025","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41467-020-15647-5","article-title":"Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis","volume":"11","author":"Tsukui","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fcell.2019.00053","article-title":"The expression and possible functions of tenascin-W during development and disease","volume":"7","author":"Tucker","year":"2019","journal-title":"Frontiers in Cell and Development Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1164\/rccm.200712-1818OC","article-title":"Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma","volume":"178","author":"Turato","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2040","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1242\/jcs.114.24.4587","article-title":"Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility","volume":"114","author":"Twal","year":"2001","journal-title":"Journal of Cell Science"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2045","doi-asserted-by":"crossref","DOI":"10.1016\/j.matbio.2015.01.021","article-title":"A novel intracellular fibulin-1D variant binds to the cytoplasmic domain of integrin beta 1 subunit","author":"Twal","year":"2015","journal-title":"Matrix Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4161\/19336918.2014.994893","article-title":"Tenascin-X: beyond the architectural function","volume":"9","author":"Valcourt","year":"2015","journal-title":"Cell Adhesion & Migration"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2055","first-page":"657","article-title":"Elastase-induced parenchymal disruption and airway hyper responsiveness in mouse precision cut lung slices: Toward an ex vivo COPD model","volume":"7","author":"Van Dijk","year":"2016","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2060","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.matbio.2015.01.005","article-title":"Matrix metalloproteinase interactions with collagen and elastin","volume":"44-46","author":"Van Doren","year":"2015","journal-title":"Matrix Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.201706-1301OC","article-title":"Nintedanib with add-on pirfenidone in idiopathic pulmonary fibrosis. Results of the INJOURNEY trial","volume":"197","author":"Vancheri","year":"2018","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2070","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41591-019-0468-5","article-title":"A cellular census of human lungs identifies novel cell states in health and in asthma","volume":"25","author":"Vieira Braga","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.trsl.2012.01.012","article-title":"Peripheral blood biomarkers in idiopathic pulmonary fibrosis","volume":"159","author":"Vij","year":"2012","journal-title":"Translational Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076451","article-title":"Type V collagen induced tolerance suppresses collagen deposition, TGF-beta and associated transcripts in pulmonary fibrosis","volume":"8","author":"Vittal","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2085","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1378\/chest.06-2453","article-title":"Angiogenesis in chronic lung disease","volume":"131","author":"Voelkel","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/01902140701634827","article-title":"Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia","volume":"33","author":"Vuorinen","year":"2007","journal-title":"Experimental Lung Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/aps.2010.170","article-title":"Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma","volume":"32","author":"Wang","year":"2011","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2100","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/onc.2014.52","article-title":"Extracellular calumenin suppresses ERK1\/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysis","volume":"34","author":"Wang","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1165\/rcmb.2005-0203OC","article-title":"Transforming growth factor-beta1 drives airway remodeling in cigarette smoke-exposed tracheal explants","volume":"33","author":"Wang","year":"2005","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2110","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1073\/pnas.1719474115","article-title":"Pulmonary alveolar type I cell population consists of two distinct subtypes that differ in cell fate","volume":"115","author":"Wang","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0228-0","article-title":"Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis through the PDGFR\/ROCK1 signal pathway","volume":"51","author":"Wang","year":"2019","journal-title":"Experimental & Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/thorax.57.4.309","article-title":"Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma","volume":"57","author":"Ward","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2125","article-title":"ACE2 expression is elevated in airway epithelial cells from aged and male donors but reduced in asthma","author":"Wark","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/thx.2005.045187","article-title":"Asthma exacerbations. 3: Pathogenesis","volume":"61","author":"Wark","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2135","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jim-2018-000785","article-title":"The characteristics and clinical significance of mucin levels in bronchoalveolar lavage fluid of patients with interstitial lung disease","volume":"67","author":"Wei","year":"2019","journal-title":"Journal of Investigative Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.2388","article-title":"New insights into form and function of fibronectin splice variants","volume":"216","author":"White","year":"2008","journal-title":"The Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2145","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1164\/rccm.200301-041OC","article-title":"Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10","volume":"168","author":"White","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2150","series-title":"Chronic obstructive pulmonary disease (COPD)","author":"WHO","year":"2017"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2155","series-title":"Weekly epidemiological and operational updates January 2021","author":"WHO","year":"2021"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2160","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00105314","article-title":"Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis","author":"Wilkes","year":"2015","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2165","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1091\/mbc.e08-06-0621","article-title":"A shared mechanism of adhesion modulation for tenascin-C and fibulin-1","volume":"20","author":"Williams","year":"2009","journal-title":"Molecular Biology of the Cell"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2170","doi-asserted-by":"crossref","first-page":"L991","DOI":"10.1152\/ajplung.00289.2018","article-title":"Characterization of human PDGFR-beta-positive pericytes from IPF and non-IPF lungs","volume":"315","author":"Wilson","year":"2018","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2180","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.actbio.2013.08.003","article-title":"Tropoelastin: a versatile, bioactive assembly module","volume":"10","author":"Wise","year":"2014","journal-title":"Acta Biomaterialia"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2185","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1183\/09031936.00174914","article-title":"Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis","volume":"45","author":"Wollin","year":"2015","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2190","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/rccm.200311-1529OC","article-title":"Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression","volume":"169","author":"Woodruff","year":"2004","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pupt.2012.08.005","article-title":"Phenotype modulation of airway smooth muscle in asthma","volume":"26","author":"Wright","year":"2013","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pupt.2012.08.003","article-title":"Functional phenotype of airway myocytes from asthmatic airways","volume":"26","author":"Wright","year":"2013","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2009.02.012","article-title":"Tgf-beta superfamily signaling in embryonic development and homeostasis","volume":"16","author":"Wu","year":"2009","journal-title":"Developmental Cell"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3389\/fphys.2016.00469","article-title":"A disintegrin and metalloprotease 17 in the cardiovascular and central nervous systems","volume":"7","author":"Xu","year":"2016","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2215","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12931-020-01445-6","article-title":"SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis","volume":"21","author":"Xu","year":"2020","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2045-3701-3-27","article-title":"Specific structure and unique function define the hemicentin","volume":"3","author":"Xu","year":"2013","journal-title":"Cell & Bioscience"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2225","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90558","article-title":"Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis","volume":"1","author":"Xu","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2230","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/415168a","article-title":"Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo","volume":"415","author":"Yanagisawa","year":"2002","journal-title":"Nature"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2021.107839_bb2235","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1513\/AnnalsATS.201503-110AW","article-title":"MUC5B and idiopathic pulmonary fibrosis","volume":"12","author":"Yang","year":"2015","journal-title":"Annals of the American Thoracic Society"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2240","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13710","article-title":"Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment","volume":"7","author":"Yang","year":"2016","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2245","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1398-9995.2011.02773.x","article-title":"Extracellular matrix in airway smooth muscle is associated with dynamics of airway function in asthma","volume":"67","author":"Yick","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2250","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/IJG.0000000000000108","article-title":"Biology of the extracellular matrix: an overview","volume":"23","author":"Yue","year":"2014","journal-title":"Journal of Glaucoma"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2255","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.21037\/jtd-20-1024","article-title":"Status and prospects: personalized treatment and biomarker for airway remodeling in asthma","volume":"12","author":"Zhang","year":"2020","journal-title":"Journal of Thoracic Disease"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2260","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41413-020-0084-5","article-title":"Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study","volume":"8","author":"Zhang","year":"2020","journal-title":"Bone Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2265","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00134-020-05990-y","article-title":"Imaging changes of severe COVID-19 pneumonia in advanced stage","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2270","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.18632\/oncotarget.23869","article-title":"Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2275","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MCP.0b013e328356d03c","article-title":"Biomarkers in idiopathic pulmonary fibrosis","volume":"18","author":"Zhang","year":"2012","journal-title":"Current Opinion in Pulmonary Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2280","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.exer.2009.09.018","article-title":"Focus on molecules: fibulin-3 (EFEMP1)","volume":"90","author":"Zhang","year":"2010","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2285","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.21037\/jtd.2017.06.63","article-title":"Sputum mucin 1 is increased during the acute phase of chronic obstructive pulmonary disease exacerbation","volume":"9","author":"Zheng","year":"2017","journal-title":"Journal of Thoracic Disease"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2290","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.matbio.2018.03.005","article-title":"Extracellular matrix in lung development, homeostasis and disease","volume":"73","author":"Zhou","year":"2018","journal-title":"Matrix Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.matbio.2016.07.011","article-title":"Fibronectin, the extracellular glue","volume":"60-61","author":"Zollinger","year":"2017","journal-title":"Matrix Biology"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2300","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1164\/rccm.200302-221OC","article-title":"Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis","volume":"168","author":"Zorzetto","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2021.107839_bb2305","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12931-020-01442-9","article-title":"Cell-specific expression of lung disease risk-related genes in the human small airway epithelium","volume":"21","author":"Zuo","year":"2020","journal-title":"Respiratory Research"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821000413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725821000413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:15:23Z","timestamp":1759011323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725821000413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":461,"alternative-id":["S0163725821000413"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107839","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic targets in lung tissue remodelling and fibrosis","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107839"}}